Euro Zone financial news

Fujifilm launches a extra complete portfolio for

Düsseldorf, July 01, 2021 (GLOBE NEWSWIRE) — At present at a digital European occasion, the newly named FUJIFILM Healthcare Europe and FUJIFILM Europe’s current European medical enterprise (hereinafter known as “Fujifilm”) introduced an entire and built-in portfolio of diagnostic services, together with CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound techniques. At present’s launch follows the completion of Fujifilm’s acquisition and takeover of Hitachi’s Diagnostic Imaging-related enterprise on 31 March 2021 for 179 billion yen (€1.3 billion), with the newly named FUJIFILM Healthcare Europe additionally launching as we speak.

Presenting a extra complete portfolio to an viewers of key opinion leaders within the medical neighborhood, prospects and the media, the synergy of FUJIFILM Healthcare Europe and Fujifilm is central to the expansion technique of the Japanese multinational in Europe, as Fujifilm appears to be like to determine itself as a healthcare market chief. Combining the 2 organisations’ product line-ups enhances Fujifilm’s total functionality to supply a complete resolution that caters to a broad vary of medical wants.

On account of this strengthened provide, Fujifilm intends to considerably broaden its diagnostics enterprise globally as one of many Group’s main development drivers, aiming to realize a turnover of 860 billion yen (€6.6 billion) inside the subsequent three years; a development of greater than 50% in comparison with the fiscal yr ending March 2020.

At present’s digital occasion introduced the European medical neighborhood with a complete healthcare portfolio. FUJIFILM Healthcare Europe’s experience in CT, MRI and ultrasound, mixed with Fujifilm’s enterprise’ core capabilities in x-ray, endoscopy, girls’s well being, AI, PACS and IVD, permit the corporate to maximise its companies and merchandise in a number of areas of prevention and prognosis for the advantage of sufferers in Europe.

Highlights of the improved portfolio that show this new energy embrace:

1)   FUJIFILM Healthcare Europe’s high-image-quality and sturdy CT mixed with Fujifilm’s AI expertise platform REiLI, and SYNAPSE 3D, which helps post-processing, providing a low dose resolution to radiology departments and complete assist from imaging to prognosis.

2)   An enhanced Fujifilm providing to a wider vary of hospital departments, together with gynaecology, surgical procedure and urology. For instance, the medical utility of FUJIFILM Healthcare Europe’s ultrasound expertise in surgical procedure offers a platform for Fujifilm’s new introduction of surgical endoscopes and SYNAPSE 3D.

3)   Expanded utility and technical assist and repair throughout the whole portfolio of Fujifilm medical merchandise.

“We’ve got labored exhausting to realize this vital milestone for Fujifilm and its future growth. At present we’re stronger collectively, and our aim is to maximise these new complete and full portfolio synergies. Our aim is to place ourselves as a market chief and primary complete accomplice for the Healthcare neighborhood in Europe within the subject of prevention and prognosis,” says Toshi Iida, President and Managing Director of FUJIFILM Europe.

“Because of this vital acquisition, we now have mixed the strengths and abilities of two main firms within the sector, and as we speak we provide a bundle of complete and cutting-edge options. Fujifilm is now an organization that gives a extra complete portfolio to healthcare suppliers throughout Europe. New milestones await us in AI, Healthcare IT, CT, MRI, ultrasound and lots of extra fields, aspiring to create new values of excellence throughout this thrilling new mixed staff,” provides Masaharu Fukumoto, Senior Vice President, FUJIFILM Europe.

“We deliver to Fujifilm many a long time of expertise out there, alongside a robust and complete product portfolio. The 2 organisations complement one another completely, and I’m excited for the service and assist we are able to provide along with a brand new mixed staff that is able to embrace new challenges and nice adventures sooner or later. Collectively we’re stronger,” mentioned Jean-Luc Budillon, President and COO, FUJIFILM Healthcare Europe.

About Fujifilm in Europe
Fujifilm operates over 50 group firms and branches in Europe and employs roughly 4,500 folks engaged in R&D, manufacturing, gross sales and repair, with FUJIFILM Europe GmbH, situated in Düsseldorf, Germany, working because the strategic headquarters for the area. All through Europe, Fujifilm entities serve a variety of industries together with medical expertise, biopharmaceuticals, digital supplies, industrial merchandise, chemical compounds, graphic techniques, optical units, information storage and all features of pictures. During the last 20 years, the corporate has extra intensively targeted on healthcare – from prognosis to prevention and therapy. At present, Fujifilm in Europe offers your complete spectrum of affected person care, along with analysis, growth and manufacturing in superior therapies, gene therapies and vaccines, in addition to offering cell tradition media and regenerative medication options.
For extra info, please go to:

About FUJIFILM Holdings Company
FUJIFILM Holdings Company, situated in Tokyo, Japan, brings innovative options to a broad vary of worldwide industries by leveraging its depth of data and basic applied sciences developed in its relentless pursuit of innovation. Its proprietary core applied sciences contribute to the assorted fields together with healthcare, graphic techniques, extremely useful supplies, optical units, digital imaging and doc merchandise. These services are based mostly on its intensive portfolio of chemical, mechanical, optical, digital and imaging applied sciences. For the fiscal yr ended March 31, 2021, the corporate had world revenues of Euro 16,7 billion, at an change fee of 131,6 yen to the Euro. Fujifilm is dedicated to accountable environmental stewardship and good company citizenship.
For extra info, please go to:

Contact info:
Luana Porfido
Head of Company Communications – Europe
+39 (0)3459529101

Andy Ross
Deputy Head of Company Communications – Europe
+44 (0)7766497949

Related posts

FLSmidth cuts as much as 16% CO2 with Europe’s first full-scale


Meet Europe’s high 10 M&A attorneys


World’s Finest Rally Has Morgan Stanley to Newton Eyeing Europe


Leave a Comment